Endoscopic Sleeve Gastroplasty (ESG) Guide

There's a moment in nearly every weight loss consultation where the patient pauses, looks at the surgeon, and says: "But isn't there something… less?" Less invasive. Less scary. Less permanent. Less disruptive to their already complicated life.

For decades, the honest answer was: not really. Diet and exercise worked for some. Bariatric surgery worked for many more. But the gap between those two options - between "try harder" and "let's reshape your internal organs" - remained stubbornly empty.

Endoscopic Sleeve Gastroplasty helped fill that gap, offering a middle option between conservative treatment and surgery for the right candidates.

What Happens During an ESG Procedure?

Endoscopic Sleeve Gastroplasty - ESG for short - is a procedure that reduces the size of your stomach by approximately 70% without making a single external incision. No scalpels. No laparoscopic ports. No scars. The entire procedure is performed through your mouth using a flexible endoscope - essentially, a long, thin tube fitted with a suturing device.

Here's the step-by-step reality:

1. Sedation: You receive either deep sedation or light general anesthesia. Many centers now perform ESG under conscious sedation alone, meaning no intubation is necessary.
2. Endoscope insertion: The gastroenterologist or bariatric endoscopist passes the endoscope through your mouth, down the esophagus, and into the stomach - the same route used for a routine diagnostic gastroscopy.
3. Suturing: Using a specialized device called the OverStitch system, the surgeon places a series of full-thickness sutures along the greater curvature of the stomach, effectively stitching the stomach wall inward. This creates a tubular, sleeve-like shape.
4. Completion: The entire procedure takes 60-90 minutes. No cuts. No staples. No organs removed.

The result is a stomach that holds roughly 30% of its original volume. You feel full faster, eat less, and - crucially - your gut hormone signaling shifts in a direction that reduces appetite naturally.

ESG vs. Surgical Gastric Sleeve: What's the Difference?

Let's be honest: ESG and surgical gastric sleeve (laparoscopic sleeve gastrectomy) are not the same procedure. They target similar anatomical outcomes - a smaller, tube-shaped stomach - but they arrive there through fundamentally different paths, with meaningfully different trade-offs.

• Invasiveness: Surgical sleeve requires 4-5 small abdominal incisions and permanently removes approximately 80% of the stomach. ESG uses no incisions and is potentially reversible.
• Weight loss magnitude: Surgical sleeve achieves 25-30% total body weight loss at 2 years. ESG achieves 15-20% - meaningful, but approximately 30-40% less than surgery.
• Recovery time: ESG patients typically resume normal activities within 1-3 days. Surgical sleeve patients require 2-4 weeks of restricted activity.
• Complication rate: ESG carries a 1-2% adverse event rate compared to 3-5% for laparoscopic sleeve gastrectomy (ASMBS).
• Durability: Five-year data for ESG is still maturing, while surgical sleeve has 15+ years of longitudinal evidence demonstrating sustained results.

Worth noting: ESG is not a replacement for surgical bariatric procedures in patients with severe obesity (BMI 40+) or significant metabolic disease. It occupies a different clinical niche - and understanding that niche is critical to making the right decision.

What Are the Complication Rates and Risks of ESG?

ESG has one of the lowest complication profiles in bariatric medicine. Published series report a serious adverse event rate of approximately 1-2%, compared with 3-5% for laparoscopic sleeve gastrectomy (ASMBS). Because the procedure involves no incisions and removes no tissue, the most common effects are temporary rather than dangerous.

• Common and expected: mild-to-moderate nausea, abdominal cramping, and acid reflux in the first 24-72 hours, typically managed with medication.
• Uncommon: persistent vomiting, dehydration, or minor gastrointestinal bleeding that usually resolves without further intervention.
• Rare serious complications (well under 1%): perigastric fluid collection, abscess, or gastric perforation - risks that are minimized by choosing an experienced, high-volume endoscopist.
• Suture loosening: approximately 5-8% of patients may need suture reinforcement or a revision within two years.

The single biggest factor influencing the ESG complication rate is operator experience. Because outcomes are highly technique-dependent, ESG should be carried out by endoscopists who have completed hundreds of documented procedures before treating international patients.

Who Is the Ideal Candidate?

ESG fills a specific gap in the obesity treatment spectrum. According to the American Society for Gastrointestinal Endoscopy (ASGE), the ideal candidate profile includes:

• BMI 30-40: Patients who fall below the traditional threshold for bariatric surgery but have failed to achieve lasting results with diet, exercise, and behavioral interventions
• Surgery-averse patients: Those who understand the benefits of anatomical intervention but are uncomfortable with permanent surgical alteration
• Professionals requiring minimal downtime: Individuals whose careers or caregiving responsibilities make a 2-4 week surgical recovery impractical
• Patients seeking a bridge procedure: For individuals with BMI above 50, ESG can serve as a first-stage weight loss procedure to reduce surgical risk before a definitive bariatric operation

What Does the ESG Procedure Feel Like?

Anxiety about the procedure itself is the number one barrier for most patients considering ESG. So what is it actually like?

Most patients describe the experience as "surprisingly anticlimactic." You arrive at the hospital in the morning. An IV line is placed. You're sedated. And then - from your perspective - you wake up, and it's done.

In the first 24-48 hours after ESG, patients commonly experience:

• Mild to moderate nausea: Controlled with anti-emetic medications. This typically resolves within 48 hours.
• Abdominal discomfort: A sensation of tightness or cramping in the upper abdomen - not sharp pain, but a persistent awareness that something has changed inside.
• Reduced appetite: The effect is immediate. Most patients are shocked by how little food they desire in the first week.

The dietary progression follows a structured path: clear liquids for 2 days, full liquids for 1 week, pureed foods for 2 weeks, then gradual reintroduction of solid foods. At accredited partner hospitals, every ESG patient receives a personalized nutrition protocol with remote dietitian access.

What Are the Long-Term Results of ESG?

ESG is a newer procedure - the first peer-reviewed outcomes data emerged around 2016-2017 - which means the long-term evidence base is still developing. But here's what we know so far:

• 12-month data: Meta-analyses published in Gastrointestinal Endoscopy show average total body weight loss of 15-20% at one year.
• 24-month data: Weight loss is generally maintained at 14-18% total body weight, with patients who adhere to dietary counseling retaining more of their initial loss.
• Comorbidity improvement: Studies report significant improvement in hypertension (65%), dyslipidemia (55%), and pre-diabetic insulin resistance (70%) at 12 months post-ESG (NHS).
• Revision rates: Approximately 5-8% of patients may require suture reinforcement or revision within 2 years, typically due to partial suture loosening.

The honest assessment: ESG delivers less absolute weight loss than surgical options, but with lower risk and faster recovery. For the right patient, it is an effective tool. For the wrong patient, it can be an expensive half-measure, which is why careful candidate selection matters.

One thing ESG does not shorten is the follow-up commitment. The nutritional and behavioral program that follows an endoscopic sleeve runs on the same 12-month timeline as the one that follows a surgical sleeve: the procedure is far less invasive, but the lifestyle changes needed to hold the result are the same.

Can You Combine ESG with GLP-1 Medications?

One of the most promising developments in 2026 is the emerging practice of combining ESG with GLP-1 medications like Semaglutide. Early data from academic centers suggests this combination can push weight loss outcomes closer to those of surgical sleeve gastrectomy - achieving 22-25% total body weight loss - while preserving the minimally invasive nature of the endoscopic approach.

This hybrid model is particularly relevant for patients in the BMI 35-40 range who want maximum results without traditional surgery.

ESG at Accredited Partner Hospitals

Choosing where to have ESG performed matters enormously. The procedure's outcomes are highly operator-dependent - meaning the endoscopist's experience directly correlates with the quality and durability of the suture pattern.

ESG should be performed by experienced gastroenterologists with extensive bariatric endoscopy training. A typical accredited-hospital package includes:

• Pre-procedure evaluation: Including upper GI endoscopy, metabolic blood panels, and BMI-based eligibility assessment
• Bundled care package: Procedure, hospital stay, hotel accommodation, airport transfers, and 12-month aftercare
• Remote nutritional follow-up: Scheduled video consultations with a dedicated bariatric dietitian at 1, 3, 6, and 12 months post-procedure

ESG offers a meaningful option for moderate obesity - not as a "lesser" treatment, but as a targeted intervention for patients who need more than lifestyle changes but less than open surgery. Matching the right patient to the right procedure starts with an honest, data-driven conversation. If you are weighing your options, our guide comparing gastric sleeve versus weight loss injections can help clarify the trade-offs.